Skip to main content
. 2021 Oct 26;13(21):5366. doi: 10.3390/cancers13215366
c-TACE Conventional TACE (using Lipiodol®)
DEB-TACE Drug-eluting bead TACE
RECIST Response evaluation criteria in solid tumors
NET Neuroendocrine tumor
OS Overall survival
mRECIST Modified response evaluation criteria in solid tumors
SSAs Somatostatin analogs
TACE Transarterial chemoembolization
TTLP Time to liver progression
TTUP Time to untreatable progression
WHO World Health Organization